Abbott Laboratories (BMV:ABT)

Market Cap	4.51T
Revenue (ttm)	865.46B
Net Income (ttm)	274.92B
Shares Out	n/a
EPS (ttm)	157.41
PE Ratio	16.40
Forward PE	24.84
Dividend	44.32 (1.70%)
Ex-Dividend Date	Apr 15, 2025

Volume	140
Average Volume	58
Open	2,603.00
Previous Close	2,603.00
Day's Range	2,603.00 - 2,603.00
52-Week Range	1,730.00 - 2,915.60
Beta	0.74
RSI	53.20
Earnings Date	Jul 16, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: ABT

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD